Financials

  • Market Capitalization 7.26 B
  • Employee 418
  • Founded 2018
  • CEO N/A
  • Website www.mirumpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00MH7T2M7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-168.06
Rapporto prezzo/fatturato
7.61

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1065
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
60.94 USD-3.94%-3.73%+17.76%+53.71%7.62 B USD
1081
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
107.49 USD-0.84%-4.88%+15.58%-2.56%7.37 B USD
1156
SRRK
Scholar Rock Holding Corporation - Common Stock
54.70 USD-3.54%-1.48%+22.07%+82.21%6.55 B USD
1159
XENE
Xenon Pharmaceuticals Inc. - Common Shares
67.72 USD-1.74%+10.83%+29.88%+66.02%6.55 B USD

Notizie